Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 May 24;14:1359–1369. doi: 10.2147/JPR.S305146

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Hale et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Adverse Events Reported in Clinical Trials of Buprenorphine Buccal Film Compared With Conventional Opioids for Chronic Pain. The percentage of patients who reported adverse events in clinical trials for buprenorphine buccal film²¹ compared with those reported for extended-release formulations of oxymorphone,⁸⁷ hydromorphone,⁸⁸ and oxycodone.⁶⁹

Notes: Copyright ©2019. Dove Medical Press. Adapted from Pergolizzi JV, Jr., Raffa RB. Safety and efficacy of the unique opioid buprenorphine for the treatment of chronic pain. J Pain Res. 2019;12:3299–3317.⁷